Neoplasms are abnormal tissue growths resulting from excessive cellular proliferation, with the immune response playing a critical role in their control and evasion. Tumors can exploit various mechanisms to evade immune detection, including the expression of immune checkpoint molecules and creating immunosuppressive environments. Paraneoplastic syndromes, occurring in 10-15% of advanced cancer patients, manifest through various clinical syndromes like endocrine, neuromyopathic, and gastrointestinal effects, which are unrelated to tumor spread.